Literature DB >> 26823877

Short-term effects of splenectomy on serum fibrosis indexes in liver cirrhosis patients.

Degang Kong1, Xiuli Chen2, Shichun Lu3, Qingliang Guo1, Wei Lai1, Jushan Wu1, Dongdong Lin1, Daobing Zeng1, Binwei Duan1, Tao Jiang1, Jilei Cao1.   

Abstract

OBJECTIVE: To determine the changing patterns of 4 liver fibrosis markers pre and post splenectomy (combined with pericardial devascularization [PCDV]) and to examine the short-term effects of splenectomy on liver fibrosis.
METHODS: Four liver fibrosis markers of 39 liver cirrhosis patients were examined pre, immediately post, 2 days post, and 1 week post (15 cases) splenectomy (combined with PCDV).
RESULTS: The laminin (LN) level decreased immediately post surgery compared with the preoperative LN level (P < 0.05). The type IV collagen level decreased immediately post surgery compared with that pre surgery (P < 0.05), it significantly increased (P < 0.05) 2 days post surgery and significantly decreased 1 week post surgery (P < 0.05). Hyaluronic acid and the procollagen III N-terminal peptide levels increased significantly 2 days post surgery compared with that pre and immediately post surgery, they significantly decreased 1 week post surgery compared to 2 days post surgery (P < 0.05).
CONCLUSIONS: In the short-term, the 4 liver fibrosis markers and the FibroScans post splenectomy showed characteristic changes, splenectomy may transiently initiate the degradation process of liver fibrosis.

Entities:  

Keywords:  4 liver fibrosis markers; Splenectomy; liver cirrhosis

Mesh:

Substances:

Year:  2015        PMID: 26823877      PMCID: PMC4713663     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  8 in total

1.  Pathology of the spleen in hepatosplenic schistosomiasis. Morphometric evaluation and extracellular matrix changes.

Authors:  C R Freitas; A A Barbosa; A L Fernandes; Z A Andrade
Journal:  Mem Inst Oswaldo Cruz       Date:  1999 Nov-Dec       Impact factor: 2.743

Review 2.  Clinical evidence for the regression of liver fibrosis.

Authors:  Elizabeth L Ellis; Derek A Mann
Journal:  J Hepatol       Date:  2012-01-13       Impact factor: 25.083

Review 3.  The extracellular matrix in hepatic regeneration.

Authors:  A Martinez-Hernandez; P S Amenta
Journal:  FASEB J       Date:  1995-11       Impact factor: 5.191

4.  Impact of splenectomy in patients with liver cirrhosis: Results from 18 patients in a single center experience.

Authors:  Satoru Imura; Mitsuo Shimada; Tohru Utsunomiya; Yuji Morine; Tetsuya Ikemoto; Hiroki Mori; Jun Hanaoka; Shuichi Iwahashi; Yu Saito; Hisami Yamanaka-Okumura; Eiji Takeda
Journal:  Hepatol Res       Date:  2010-09       Impact factor: 4.288

5.  Splenectomy reduces fibrosis and preneoplastic lesions with increased triglycerides and essential fatty acids in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.

Authors:  Toshiyuki Oishi; Shuji Terai; Takuya Iwamoto; Taro Takami; Naoki Yamamoto; Isao Sakaida
Journal:  Hepatol Res       Date:  2011-03-21       Impact factor: 4.288

Review 6.  Macrophages: master regulators of inflammation and fibrosis.

Authors:  Thomas A Wynn; Luke Barron
Journal:  Semin Liver Dis       Date:  2010-07-21       Impact factor: 6.115

7.  Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography.

Authors:  Mireen Friedrich-Rust; Katrin Wunder; Susanne Kriener; Fariba Sotoudeh; Swantje Richter; Joerg Bojunga; Eva Herrmann; Thierry Poynard; Christoph F Dietrich; Johannes Vermehren; Stefan Zeuzem; Christoph Sarrazin
Journal:  Radiology       Date:  2009-08       Impact factor: 11.105

Review 8.  Evolving therapies for liver fibrosis.

Authors:  Detlef Schuppan; Yong Ook Kim
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

  8 in total
  4 in total

1.  Effect of entecavir in the treatment of patients with hepatitis B virus-related compensated and decompensated cirrhosis.

Authors:  Xiao-Dong Gai; Wei-Feng Wu
Journal:  Exp Ther Med       Date:  2017-08-18       Impact factor: 2.447

2.  Research on Portal Venous Hemodynamics and Influencing Factors of Portal Vein System Thrombosis for Wilson's Disease after Splenectomy.

Authors:  Zhou Zheng; Qingsheng Yu; Hui Peng; Wanzong Zhang; Yi Shen; Hui Feng; Long Huang; Fuhai Zhou; Qi Zhang; Qin Wang
Journal:  Front Surg       Date:  2022-05-30

3.  The Effect of Splenectomy on the Reversal of Cirrhosis: a Prospective Study.

Authors:  Dao-Bing Zeng; Liang Di; Rui-Chi Zhang; Qing-Liang Guo; Bin-Wei Duan; Cui-Yu Jia; Feng Chen; Dong-Dong Lin; Yun-Jin Zang; Shi-Chun Lu
Journal:  Gastroenterol Res Pract       Date:  2019-04-08       Impact factor: 2.260

4.  Diagnostic Value of Serum Procollagen III N-Terminal Peptide for Liver Fibrosis in Infantile Cholestasis.

Authors:  Yingcan Wang; Weihua Pan; Dongying Zhao; Yan Chen; Xuting Chen; Hongping Xia
Journal:  Front Pediatr       Date:  2020-03-31       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.